Borderline Personality Disorder Clinical Trial
Official title:
Evaluation of a Modified Dialectical Behavior Therapy Program for Borderline Personality Disorder
Verified date | November 2014 |
Source | University of Manitoba |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The goal of this pilot project is to offer outpatient Dialectical Behavior Therapy (DBT)
treatment as described in Linehan's text (1993), which is considered an effective treatment
of borderline personality disorder. This treatment consists of weekly individual
psychotherapy, weekly group skills training, 24 hour telephone consultation, and weekly team
consultation meetings for therapists. The investigators program is able to offer all of
these components except the 24 hour phone consultation (which has been modified due to
employment/union guidelines of interdisciplinary staff working within the investigators
health care system). This project intends to offer the treatment for a period of 6 months.
As such, this proposed research project seeks to assess the feasibility of implementing an
outpatient DBT program within a public health care setting in Canada. This study also aims
to evaluate this DBT program for clinical effectiveness in its modified format.
Specifically, the investigators will examine relevant outcomes related to patient
functioning (e.g., depression, self-harm and suicidal behaviors, and admissions to
hospital/ER visits) and improvement (e.g., improved quality of life, meeting work/employment
goals) pre and post completion of this 6 month treatment program.
The investigators hypotheses are that each patient will show improvement in all outcome
variables (e.g., improved mood and quality of life, decreased self-harm, decreased ER visits
and hospitalization visits, etc). The investigators also hypothesize that the investigators
modified program will produce comparable results to those from studies of standard
outpatient DBT.
Status | Completed |
Enrollment | 16 |
Est. completion date | January 2016 |
Est. primary completion date | January 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Diagnosis of Borderline Personality Disorder - Chronic suicidal ideation or parasuicidal acts, or other self-destructive, impulsive behaviors - Must be enrolled in dialectical behavior therapy program Exclusion Criteria: - Active psychosis - Severe developmental delays, cognitive impairment or learning disabilities - History of or current violent/aggressive behaviors |
Country | Name | City | State |
---|---|---|---|
Canada | Victoria General Hospital | Winnipeg | Manitoba |
Lead Sponsor | Collaborator |
---|---|
University of Manitoba |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Quality of Life Enjoyment and Satisfaction Questionnaire | This measure assesses the degree of enjoyment and satisfaction experienced during the past week in several areas: physical health, feelings, work, household duties, school, leisure time, and social relationships. | Baseline | |
Primary | Quality of Life Enjoyment and Satisfaction Questionnaire | This measure assesses the degree of enjoyment and satisfaction experienced during the past week in several areas: physical health, feelings, work, household duties, school, leisure time, and social relationships. | Change - baseline to 6 months | |
Primary | Quality of Life Enjoyment and Satisfaction Questionnaire | This measure assesses the degree of enjoyment and satisfaction experienced during the past week in several areas: physical health, feelings, work, household duties, school, leisure time, and social relationships. | Change - 6 months to 12 months | |
Primary | Quality of Life Enjoyment and Satisfaction Questionnaire | This measure assesses the degree of enjoyment and satisfaction experienced during the past week in several areas: physical health, feelings, work, household duties, school, leisure time, and social relationships. | Change - 12 months to 18 months | |
Secondary | Borderline Symptom List 23 | Baseline | ||
Secondary | Borderline Symptom List 23 | Change - baseline to 6 months | ||
Secondary | Borderline Symptom List 23 | Change - 6 months to 12 months | ||
Secondary | Borderline Symptom List 23 | Chabge - 12 months to 18 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04856449 -
DBT Skills Plus EMDR for BPD and Trauma
|
N/A | |
Active, not recruiting |
NCT04587518 -
Five Factor Model Treatment for Borderline Personality Disorder
|
N/A | |
Recruiting |
NCT05651295 -
A Precision Medicine Approach to Target Engagement for Emotion Regulation
|
N/A | |
Completed |
NCT03677037 -
The Short-Term MBT Project
|
Phase 3 | |
Not yet recruiting |
NCT05989529 -
Delving Into Borderline Personality Disorder Clinical Trial Experiences
|
||
Completed |
NCT02068326 -
MBT in Groups for Adolescents With BPD or Subthreshold BPD Versus TAU - the M-GAB Randomized Controlled Trial
|
N/A | |
Completed |
NCT02518906 -
Evaluation of AIT Study
|
N/A | |
Recruiting |
NCT04296604 -
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
|
N/A | |
Terminated |
NCT02149823 -
Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations
|
Phase 1 | |
Completed |
NCT02108990 -
Acetaminophen and Social Processes
|
Phase 2 | |
Completed |
NCT02988037 -
Adapted Dialectical Behaviour Therapy for Adolescents With Deliberate Self-Harm: A Pre-post Observational Study
|
N/A | |
Not yet recruiting |
NCT01683136 -
Evaluation of the HBDL Coil Transcranial Magnetic Stimulation (TMS) Device - Feasibility Study for the Treatment of Borderline Personality Disorder
|
N/A | |
Completed |
NCT02397031 -
Mindfulness and Interpersonal Effectiveness Skills in Borderline Personality Disorder
|
N/A | |
Terminated |
NCT01103180 -
Selective Serotonin Reuptake Inhibitors (SSRIs) in Borderline Personality Disorder
|
Phase 2 | |
Terminated |
NCT01212588 -
Preliminary Trial of the Effect of Glucocorticoid Receptor Antagonist on Borderline Personality Disorder (BPD)
|
Phase 2 | |
Terminated |
NCT00539188 -
N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD
|
Phase 2 | |
Recruiting |
NCT05398627 -
Neurofeedback for Borderline Personality Disorder
|
N/A | |
Recruiting |
NCT03994510 -
SHame prOpensity in bOrderline Personality Disorder
|
N/A | |
Recruiting |
NCT06005129 -
Personality Change Study for Borderline Personality Disorder
|
N/A | |
Recruiting |
NCT06406972 -
Brief Admission by Self-referral for Individuals With Self-harm: Effects on Compulsory Care
|